Immune-Related Adverse Event Likelihood Score Identifies "Pure" IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population.
Mazzarella L, Giugliano F, Nicolo E, Esposito A, Crimini E, Tini G, Uliano J, Corti C, D'Amico P, Aliaga PT, Valenza C, Repetto M, Antonarelli G, Ascione L, Vivanet G, Berton Giachetti P, Minchella I, Belli C, Locatelli M, Criscitiello C, Curigliano G.
Mazzarella L, et al. Among authors: vivanet g.
Oncologist. 2024 Feb 2;29(2):e266-e274. doi: 10.1093/oncolo/oyad239.
Oncologist. 2024.
PMID: 37715957
Free PMC article.